BlackRock
VNRX icon

BlackRock’s VolitionRx Ltd VNRX Stock Holding History

BlackRock’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1K Sell
22,308
-1
-0% -$2 ﹤0.01% 5291
2026
Q1 		$90.1K Buy
22,309
+50
+0.2% +$239 ﹤0.01% 4981
2025
Q4 		$114K Hold
22,259
– – ﹤0.01% 4868
2025
Q3 		$302K Hold
22,259
– – ﹤0.01% 4589
2025
Q2 		$338K Hold
22,259
– – ﹤0.01% 4535
2025
Q1 		$254K Hold
22,259
– – ﹤0.01% 4556
2024
Q4 		$267K Hold
22,259
– – ﹤0.01% 4564
2024
Q3 		$268K Sell
22,259
-3,545
-14% -$45.6K ﹤0.01% 4464
2024
Q2 		$312K Sell
25,804
-2,884
-10% -$42.2K ﹤0.01% 4450
2024
Q1 		$434K Sell
28,688
-158
-0.5% -$3.1K ﹤0.01% 4405
2023
Q4 		$414K Buy
28,846
+1,217
+4% +$17.9K ﹤0.01% 4466
2023
Q3 		$381K Sell
27,629
-772
-3% -$19.1K ﹤0.01% 4493
2023
Q2 		$790K Buy
28,401
+1,011
+4% +$33.3K ﹤0.01% 4345
2023
Q1 		$1.05M Buy
27,390
+335
+1% +$14K ﹤0.01% 4323
2022
Q4 		$1.31M Buy
27,055
+158
+0.6% +$6.13K ﹤0.01% 4319
2022
Q3 		$732K Sell
26,897
-129
-0.5% -$4.88K ﹤0.01% 4592
2022
Q2 		$1.11M Sell
27,026
-367
-1% -$18.5K ﹤0.01% 4500
2022
Q1 		$1.65M Buy
27,393
+282
+1% +$16K ﹤0.01% 4464
2021
Q4 		$1.7M Buy
27,111
+243
+0.9% +$16.6K ﹤0.01% 4473
2021
Q3 		$1.67M Sell
26,868
-716
-3% -$45.3K ﹤0.01% 4392
2021
Q2 		$1.82M Sell
27,584
-68,674
-71% -$4.65M ﹤0.01% 4315
2021
Q1 		$7.28M Buy
96,258
+2,626
+3% +$225K ﹤0.01% 3756
2020
Q4 		$7.29M Buy
93,632
+4,869
+5% +$335K ﹤0.01% 3529
2020
Q3 		$5.7M Buy
88,763
+4,052
+5% +$275K ﹤0.01% 3511
2020
Q2 		$6.59M Buy
84,711
+84,300
+20,511% +$6.09M ﹤0.01% 3418
2020
Q1 		$26K Buy
411
+29
+8% +$2.42K ﹤0.01% 4580
2019
Q4 		$36K Buy
382
+6
+2% +$622 ﹤0.01% 4582
2019
Q3 		$42K Buy
376
+21
+6% +$1.67K ﹤0.01% 4558
2019
Q2 		$22K Buy
355
+28
+9% +$1.81K ﹤0.01% 4674
2019
Q1 		$21K Buy
327
+23
+8% +$1.28K ﹤0.01% 4595
2018
Q4 		$11K Buy
304
+29
+11% +$1.38K ﹤0.01% 4661
2018
Q3 		$14K Buy
275
+8
+3% +$329 ﹤0.01% 4695
2018
Q2 		$11K Buy
267
+18
+7% +$805 ﹤0.01% 4740
2018
Q1 		$12K Sell
249
-312
-56% -$18.3K ﹤0.01% 4629
2017
Q4 		$33K Buy
561
+12
+2% +$702 ﹤0.01% 4491
2017
Q3 		$29K Buy
549
+20
+4% +$1.17K ﹤0.01% 4541
2017
Q2 		$38K Buy
529
+25
+5% +$1.8K ﹤0.01% 4567
2017
Q1 		$41K Buy
+504
New +$44.6K ﹤0.01% 4496
2016
Q4 		– Sell
-50
Closed -$5K – 3817
2016
Q3 		$5K Hold
50
– – ﹤0.01% 3514
2016
Q2 		$3K Hold
50
– – ﹤0.01% 3601
2016
Q1 		$4K Hold
50
– – ﹤0.01% 3389
2015
Q4 		$5K Buy
+50
New +$4.24K ﹤0.01% 3167

Other funds holding VNRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock's VNRX Position: Q2 2026 in Review

BlackRock reduced its VolitionRx Ltd (VNRX) stake by 0% in Q2 2026, selling an estimated $2 and leaving 22,308 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5291.

BlackRock first reported a position in VNRX in Q4 2015 and has held it in 42 quarters since. The position peaked at $7.29M in Q4 2020. 19 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • BlackRock held 22,308 shares of VolitionRx Ltd worth $30.1K as of Q2 2026.
  • BlackRock sold 1 VolitionRx Ltd share in Q2 2026, an estimated $2.
  • VolitionRx Ltd made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5291 holding.
  • BlackRock first reported a position in VolitionRx Ltd in Q4 2015 and has held it in 42 quarters since.
  • BlackRock's VolitionRx Ltd position peaked at $7.29M in Q4 2020.
  • 19 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.